Search EBS
Emergent BioSolutions Inc.
NYSE · CIK 1367644
Last close6.33
Daily change-0.04 (-0.63%)
10 Years gain-79.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
EBS · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
26.2Momentum
49.1Acceleration
49.5Confidence
90.0Annual Revenue17
Quarterly Revenue68
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth2.0 / 25
Quality3.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet10.4 / 15
Shareholder Economics6.6 / 10
Forward Indicators3.4 / 5
Signals
Gross margin expansionGross margin improved by 18.6314 percentage points.
ROIC expansionROIC improved by 0.0336 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 9.9476%.
Warnings
Receivables anomaly · MEDIUMAccounts receivable growth is materially above revenue growth.
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Key Metrics
Revenue Growth TTM-28.82%OK
Revenue CAGR 3Y-12.72%OK
Gross Margin57.78%OK
Operating Margin-4.79%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-2.82%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-9.95%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $742.90M | $416.70M | $100.10M | $170.60M | $156.80M | 56.09% | 13.47% | 21.11% | 6.54% | 56.7M |
| 2025 FY Dec 31, 2024 | $1.04B | $362.30M | -$108.70M | $58.70M | $35.80M | 34.72% | -10.42% | 3.43% | -6.9% | 53M |
| 2025 FY Dec 31, 2023 | $1.05B | $343.90M | -$726.40M | -$206.30M | -$257.90M | 32.77% | -69.23% | -24.58% | -32.19% | 51.2M |
| 2024 FY Dec 31, 2022 | $1.12B | $357.80M | -$170.00M | -$34.10M | -$149.90M | 32.02% | -15.21% | -13.41% | -6.64% | 50.1M |
| 2023 FY Dec 31, 2021 | $1.77B | $891.30M | $341.40M | $320.20M | $96.10M | 50.25% | 19.25% | 5.42% | 13.73% | 54.1M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $762.40M | sum latest 4 fiscal quarters Revenue | OK | 0001367644-26-000082, 0001367644-25-000202 |
| Revenue Growth TTM | -28.82% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001367644-26-000082, 0001367644-25-000202 |
| Revenue CAGR 3Y | -12.72% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001367644-26-000015 |
| Revenue CAGR 5Y | -13.74% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001367644-26-000015 |
| Gross Profit CAGR 3Y | 5.21% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001367644-26-000015 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001367644-26-000082, 0001367644-25-000202 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 57.78% | Gross Profit / Revenue | OK | 0001367644-26-000082, 0001367644-25-000202 |
| Operating Margin | -4.79% | Operating Income / Revenue | OK | 0001367644-26-000082, 0001367644-25-000202 |
| ROIC | -2.82% | NOPAT / Average Invested Capital | OK | 0001367644-26-000082, 0001367644-25-000202 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001367644-26-000082 |
| Current Ratio | 5.42x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.24x | (Cash + Short-term Investments) / Total Debt | OK | 0001367644-26-000082 |
| Revenue per Diluted Share | $14.78 | Revenue / Diluted Shares | OK | 0001367644-26-000082, 0001367644-25-000202 |